David G. Kelly
Executive Vice President, Company Secretary and Ma
immunology
ImmunoGen
Cambodia
Biography
David joined Horizon Pharma in September 2014 as executive vice president, managing director, Ireland and was appointed company secretary in November 2014. Prior to joining Horizon Pharma, he served as chief financial officer for Vidara Therapeutics, and was previously chief financial officer of AGI Therapeutics. He also served as senior vice president of Warner Chilcott (formerly Galen), a fully integrated specialty pharmaceutical company. While at Warner Chilcott, he led the company’s successful IPO on NASDAQ. In addition, David has held roles with Elan Corporation and KPMG.
Research Interest
David joined Horizon Pharma in September 2014 as executive vice president, managing director, Ireland and was appointed company secretary in November 2014. Prior to joining Horizon Pharma, he served as chief financial officer for Vidara Therapeutics, and was previously chief financial officer of AGI Therapeutics. He also served as senior vice president of Warner Chilcott (formerly Galen), a fully integrated specialty pharmaceutical company. While at Warner Chilcott, he led the company’s successful IPO on NASDAQ. In addition, David has held roles with Elan Corporation and KPMG.
